Latest & greatest articles for acute pain

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on acute pain or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on acute pain and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for acute pain

141. CMI magnetocardiograph model 2409 (CardioMag Imaging Inc.) for diagnosis of acute chest pain

CMI magnetocardiograph model 2409 (CardioMag Imaging Inc.) for diagnosis of acute chest pain CMI magnetocardiograph model 2409 (CardioMag Imaging Inc.) for diagnosis of acute chest pain CMI magnetocardiograph model 2409 (CardioMag Imaging Inc.) for diagnosis of acute chest pain Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation CMI magnetocardiograph model 2409 (...) (CardioMag Imaging Inc.) for diagnosis of acute chest pain. Lansdale: HAYES, Inc.. Healthcare Technology Brief Publication. 2011 Authors' objectives Coronary artery disease is the leading cause of death in the United States and a major health problem worldwide. Consequently, there is a need to optimize the early diagnosis of cardiac ischemic events to ensure timely treatment, avoid unnecessary hospital admissions for noncardiac chest pain, and prevent discharge of patients who are experiencing

Health Technology Assessment (HTA) Database.2011

142. Is intranasal fentanyl better than parenteral morphine for managing acute pain in children?

Is intranasal fentanyl better than parenteral morphine for managing acute pain in children? BestBets: Is intranasal fentanyl better than parenteral morphine for managing acute pain in children? Is intranasal fentanyl better than parenteral morphine for managing acute pain in children? Report By: Sandeep Rahul Kusre - Senior House Officer Search checked by Jonathan Costello - Consultant A&E Institution: Royal Free Hospital Current web editor: Stewart Teece - Clinical Research Fellow Date (...) Submitted: 5th April 2009 Date Completed: 30th November 2011 Last Modified: 30th November 2011 Status: Green (complete) Three Part Question In [children presenting to Accident & Emergency in acute pain] is [intranasal fentanyl a better analgesic than intravenous or intramuscular morphine] at [reducing pain] Clinical Scenario A child presents to the paediatric emergency department in acute pain but you cannot give him intranasal diamorphine due to both a departmental and nationwide shortage. You are able

BestBETS2011

143. Randomized clinical trial comparing the safety and efficacy of a hydromorphone titration protocol to usual care in the management of adult emergency department patients with acute severe pain

Randomized clinical trial comparing the safety and efficacy of a hydromorphone titration protocol to usual care in the management of adult emergency department patients with acute severe pain 21507527 2011 09 29 2011 11 29 2013 11 21 1097-6760 58 4 2011 Oct Annals of emergency medicine Ann Emerg Med Randomized clinical trial comparing the safety and efficacy of a hydromorphone titration protocol to usual care in the management of adult emergency department patients with acute severe pain. 352-9 (...) 10.1016/j.annemergmed.2011.03.003 We test the efficacy and safety of the "1+1" (1 mg plus 1 mg 15 minutes later if needed) hydromorphone protocol against usual care of emergency department (ED) patients with acute severe pain. This was a prospective, randomized clinical trial of ED patients with acute severe pain. The 1+1 protocol specifies administration of 1 mg intravenous hydromorphone, followed by a second dose of 1 mg intravenous hydromorphone 15 minutes after the first bolus if the patient

EvidenceUpdates2011

144. The CT-STAT (Coronary Computed Tomographic Angiography for Systematic Triage of Acute Chest Pain Patients to Treatment) Trial

The CT-STAT (Coronary Computed Tomographic Angiography for Systematic Triage of Acute Chest Pain Patients to Treatment) Trial 21939822 2011 09 23 2011 11 08 2016 11 25 1558-3597 58 14 2011 Sep 27 Journal of the American College of Cardiology J. Am. Coll. Cardiol. The CT-STAT (Coronary Computed Tomographic Angiography for Systematic Triage of Acute Chest Pain Patients to Treatment) trial. 1414-22 10.1016/j.jacc.2011.03.068 The purpose of this study was to compare the efficiency, cost, and safety (...) of a diagnostic strategy employing early coronary computed tomographic angiography (CCTA) to a strategy employing rest-stress myocardial perfusion imaging (MPI) in the evaluation of acute low-risk chest pain. In the United States, >8 million patients require emergency department evaluation for acute chest pain annually at an estimated diagnostic cost of >$10 billion. This multicenter, randomized clinical trial in 16 emergency departments ran between June 2007 and November 2008. Patients were randomly

EvidenceUpdates2011

145. A simulation model of clinical and economic outcomes of cardiac CT triage of patients with acute chest pain in the emergency department

A simulation model of clinical and economic outcomes of cardiac CT triage of patients with acute chest pain in the emergency department A simulation model of clinical and economic outcomes of cardiac CT triage of patients with acute chest pain in the emergency department A simulation model of clinical and economic outcomes of cardiac CT triage of patients with acute chest pain in the emergency department Goehler A, Ollendorf DA, Jaeger M, Ladapo J, Neumann T, Gazelle GS, Pearson SD Record (...) Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study examined the cost-effectiveness of coronary computed tomography (CT) angiography in the emergency department triage of low-risk patients with acute chest pain, non-significant

NHS Economic Evaluation Database.2011

146. Efficacy of low-dose celecoxib in patients with acute pain

Efficacy of low-dose celecoxib in patients with acute pain 21459680 2011 07 06 2011 11 03 2015 11 19 1528-8447 12 7 2011 Jul The journal of pain : official journal of the American Pain Society J Pain Efficacy of low-dose celecoxib in patients with acute pain. 756-63 10.1016/j.jpain.2010.12.014 The sore throat pain model was used to evaluate single-dose effects of celecoxib 50 and 100 mg over 6 hours in the treatment of acute pharyngeal pain. Multiple-dose effects of 50-mg bid and 100 mg (...) followed by 50 mg over 6 to 24 hours were also evaluated. Under double-blind, randomized, placebo-controlled conditions, 269 adults with confirmed acute pharyngitis rated throat pain intensity, throat soreness, difficulty swallowing, and sore throat pain relief over 24 hours. For the primary efficacy analysis (SPID2), patients receiving celecoxib 100 mg during the first 2 hours after the first dose had significantly higher mean scores than patients in the placebo group (P < .0003). Efficacy was also

EvidenceUpdates2011

147. Cost-effectiveness of coronary computed tomography and cardiac stress imaging in the emergency department: a decision analytic model comparing diagnostic strategies for chest pain in patients at low risk of acute coronary syndromes

Cost-effectiveness of coronary computed tomography and cardiac stress imaging in the emergency department: a decision analytic model comparing diagnostic strategies for chest pain in patients at low risk of acute coronary syndromes Cost-effectiveness of coronary computed tomography and cardiac stress imaging in the emergency department: a decision analytic model comparing diagnostic strategies for chest pain in patients at low risk of acute coronary syndromes Cost-effectiveness of coronary (...) computed tomography and cardiac stress imaging in the emergency department: a decision analytic model comparing diagnostic strategies for chest pain in patients at low risk of acute coronary syndromes Priest VL, Scuffham PA, Hachamovitch R, Marwick TH Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment

NHS Economic Evaluation Database.2011

148. Strain-Counterstrain therapy combined with exercise is not more effective than exercise alone on pain and disability in people with acute low back pain: a randomised trial

Strain-Counterstrain therapy combined with exercise is not more effective than exercise alone on pain and disability in people with acute low back pain: a randomised trial 21684490 2011 06 20 2011 07 14 2014 07 30 1836-9553 57 2 2011 Journal of physiotherapy J Physiother Strain-Counterstrain therapy combined with exercise is not more effective than exercise alone on pain and disability in people with acute low back pain: a randomised trial. 91-8 10.1016/S1836-9553(11)70019-4 Is Strain (...) -Counterstrain treatment combined with exercise therapy more effective than exercise alone in reducing levels of pain and disability in people with acute low back pain? Randomised trial with concealed allocation, assessor blinding, and intention-to-treat analysis. 89 (55 female) participants between 18 and 55 years experiencing acute low back pain were randomised to experimental (n = 44) and control (n = 45) groups. Participants attended four treatments in two weeks. The experimental group received Strain

EvidenceUpdates2011

149. Do bisphosphonates relieve pain caused by acute osteoporotic vertebral compression fractures?

Do bisphosphonates relieve pain caused by acute osteoporotic vertebral compression fractures? BestBets: Do bisphosphonates relieve pain caused by acute osteoporotic vertebral compression fractures? Do bisphosphonates relieve pain caused by acute osteoporotic vertebral compression fractures? Report By: Dr Emma Jenkinson - (Foundation Year One) Search checked by Dr Jamie Coleman, Professor Robin Ferner and Dr Suresh Babu - SpR in Clinical Pharmacology, Consultant Clinical Pharmacologist (...) and Consultant Interventional Radiologist respectively Institution: City Hospital, Birmingham, United Kingdom Date Submitted: 27th July 2006 Date Completed: 9th March 2011 Last Modified: 10th March 2011 Status: Green (complete) Three Part Question In [patients with an acute osteoporotic vertebral compression fractures] do [bisphosphonates] reduce [pain]? Clinical Scenario A 72-year-old woman presents to the emergency department with severe back pain after a mechanical fall. Plain radiographs of her thoracic

BestBETS2011

150. Thoracic spine thrust manipulation versus cervical spine thrust manipulation in patients with acute neck pain: a randomized clinical trial

Thoracic spine thrust manipulation versus cervical spine thrust manipulation in patients with acute neck pain: a randomized clinical trial 21335931 2011 04 04 2011 06 02 2015 11 19 0190-6011 41 4 2011 Apr The Journal of orthopaedic and sports physical therapy J Orthop Sports Phys Ther Thoracic spine thrust manipulation versus cervical spine thrust manipulation in patients with acute neck pain: a randomized clinical trial. 208-20 10.2519/jospt.2011.3640 Randomized clinical trial. To determine (...) Trial Video-Audio Media 2011 02 18 United States J Orthop Sports Phys Ther 7908150 0190-6011 IM Acute Disease Adult Analysis of Variance Cervical Vertebrae Disability Evaluation Exercise Therapy methods Female Humans Male Manipulation, Spinal methods Middle Aged Neck Pain rehabilitation Pain Measurement Range of Motion, Articular Surveys and Questionnaires Thoracic Vertebrae Treatment Outcome 2011 2 22 6 0 2011 2 22 6 0 2011 6 3 6 0 ppublish 21335931 2563 10.2519/jospt.2011.3640

EvidenceUpdates2011

151. Limited evidence does not support use of gabapentin as stand-alone therapy for acute postoperative pain

Limited evidence does not support use of gabapentin as stand-alone therapy for acute postoperative pain Limited evidence does not support use of gabapentin as stand-alone therapy for acute postoperative pain ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Take advantage of endorsed, discounted business products Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Make (...) health website Evidence Education About * Associated Topics Limited evidence does not support use of gabapentin as stand-alone therapy for acute postoperative pain Arthur Jeske DMD, PhD; James Zahrowski DMD, MS, PharmD . Overview Systematic Review Conclusion Gabapentin (250 mg) is statistically superior to placebo for treating established acute postoperative pain. However, to achieve at least 50 percent pain relief over six hours, the number of patients needed to treat was 11, which suggests

ADA Center for Evidence-Based Dentistry2011

152. Limited evidence does not support use of gabapentin as stand-alone therapy for acute postoperative pain

Limited evidence does not support use of gabapentin as stand-alone therapy for acute postoperative pain Limited evidence does not support use of gabapentin as stand-alone therapy for acute postoperative pain ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Make a difference with dentistry's premier charitable organization Take (...) website Evidence Education About * Associated Topics Limited evidence does not support use of gabapentin as stand-alone therapy for acute postoperative pain Arthur Jeske DMD, PhD; James Zahrowski DMD, MS, PharmD . Overview Systematic Review Conclusion Gabapentin (250 mg) is statistically superior to placebo for treating established acute postoperative pain. However, to achieve at least 50 percent pain relief over six hours, the number of patients needed to treat was 11, which suggests gabapentin has

ADA Center for Evidence-Based Dentistry2011

153. WITHDRAWN: Gabapentin for acute and chronic pain.

WITHDRAWN: Gabapentin for acute and chronic pain. BACKGROUND: February 2009: The authors are aware of unpublished trial data for Gabapentin which could affect the results of this review. This information together with that from trials published since 2005, will be considered when this review is updated in 2009.Anticonvulsant drugs have been used in the management of pain since the 1960s. The clinical impression is that they are useful for chronic neuropathic pain, especially when the pain (...) is lancinating or burning. OBJECTIVES: To evaluate the analgesic effectiveness and adverse effects of gabapentin for pain management in clinical practice. SEARCH STRATEGY: Randomised trials of gabapentin in acute, chronic or cancer pain were identified by MEDLINE (1966 to Nov 2004), EMBASE (1994 to Nov 2004), SIGLE (1980 to Jan 2004) and the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library, Issue 4, 2004). Additional studies were identified from the reference list

Cochrane2011

154. Pain relief for reduction of acute anterior shoulder dislocations: a prospective randomized study comparing intravenous sedation with intra-articular lidocaine

Pain relief for reduction of acute anterior shoulder dislocations: a prospective randomized study comparing intravenous sedation with intra-articular lidocaine 21164304 2010 12 17 2011 04 12 2013 11 21 1531-2291 25 1 2011 Jan Journal of orthopaedic trauma J Orthop Trauma Pain relief for reduction of acute anterior shoulder dislocations: a prospective randomized study comparing intravenous sedation with intra-articular lidocaine. 5-10 10.1097/BOT.0b013e3181d3d338 The aim was to compare (...) the effectiveness of intra-articular lidocaine (IAL) versus intravenous Demerol and Diazepam (IVS) in reduction of acute anterior shoulder dislocation. This is a prospective randomized study. Emergency room setting. Thirty-one dislocations reduced with IVS, whereas 32 patients were reduced using IAL. The visual analog pain scale was used before analgesic administration and during the closed manipulative reduction. Length of time since dislocation, frequency of dislocation, ease of reduction, patient

EvidenceUpdates2011

155. The Chiropractic Hospital-based Interventions Research Outcomes (CHIRO) study: a randomized controlled trial on the effectiveness of clinical practice guidelines in the medical and chiropractic management of patients with acute mechanical low back pain

The Chiropractic Hospital-based Interventions Research Outcomes (CHIRO) study: a randomized controlled trial on the effectiveness of clinical practice guidelines in the medical and chiropractic management of patients with acute mechanical low back pain 20889389 2010 11 24 2011 03 07 2015 11 19 1878-1632 10 12 2010 Dec The spine journal : official journal of the North American Spine Society Spine J The Chiropractic Hospital-based Interventions Research Outcomes (CHIRO) study: a randomized (...) controlled trial on the effectiveness of clinical practice guidelines in the medical and chiropractic management of patients with acute mechanical low back pain. 1055-64 10.1016/j.spinee.2010.08.019 Evidence-based clinical practice guidelines (CPGs) for the management of patients with acute mechanical low back pain (AM-LBP) have been defined on an international scale. Multicenter clinical trials have demonstrated that most AM-LBP patients do not receive CPG-based treatments. To date, the value

EvidenceUpdates2011

156. Cochrane systematic review: Topical NSAIDs provide effective relief of acute musculoskeletal pain compared to placebo, with no increase in risk of adverse effects

Cochrane systematic review: Topical NSAIDs provide effective relief of acute musculoskeletal pain compared to placebo, with no increase in risk of adverse effects Topical NSAIDs provide effective relief of acute musculoskeletal pain compared to placebo, with no increase in risk of adverse effects | Evidence-Based Nursing This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in via your Society Log in using your username and password For personal (...) accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in via your Society Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Topical NSAIDs provide effective relief of acute musculoskeletal pain compared to placebo, with no increase in risk of adverse effects Article Text Pain

Evidence-Based Nursing (Requires free registration)2011

157. BRAHMS copeptin assay to rule out myocardial infarction in patients with acute chest pain

BRAHMS copeptin assay to rule out myocardial infarction in patients with acute chest pain BRAHMS copeptin assay to rule out myocardial infarction in patients with acute chest pain | Guidance and guidelines | NICE BRAHMS copeptin assay to rule out myocardial infarction in patients with acute chest pain Medical technologies guidance [MTG4] Published date: June 2011 Guidance In November 2016, NICE reviewed this guidance and recommended that the guidance should be withdrawn. The guidance

National Institute for Health and Clinical Excellence - Medical technologies2011

158. Diclofenac (Mobigel Spray) - For the local symptomatic relief of mild to moderate pain and inflammation following acute blunt trauma of small and medium-sized joints and periarticular structures

Diclofenac (Mobigel Spray) - For the local symptomatic relief of mild to moderate pain and inflammation following acute blunt trauma of small and medium-sized joints and periarticular structures Published 13 December 2010 Statement of Advice diclofenac 4% spray gel (Mobigel Spray ®) (No: 667/10) Goldshield Group Plc 05 November 2010 ADVICE: in the absence of a submission from the holder of the marketing authorisation diclofenac 4% spray gel (Mobigel Spray ®): is not recommended for use within (...) NHS Scotland. Indication under review: for the local symptomatic relief of mild to moderate pain and inflammation following acute blunt trauma of small and medium-sized joints and periarticular structures. The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland. Advice context: No part of this advice may be used without the whole of the advice being quoted in full. This advice

Scottish Medicines Consortium2011

159. The Effect of Nitric Oxide on Pain From Acute Vascular Occlusion Crisis in Sickle Cell Disease: A Systematic Review

The Effect of Nitric Oxide on Pain From Acute Vascular Occlusion Crisis in Sickle Cell Disease: A Systematic Review "The Effect of Nitric Oxide on Pain From Acute Vascular Occlusion Crisi" by Kristina Huffaker < > > > > > Title Author Date of Award Spring 4-2011 Degree Type Capstone Project Degree Name Master of Science in Physician Assistant Studies First Advisor Torry Cobb, DHSc, MPH, PA-C Second Advisor Annjanette Sommers MS, PAC Rights . Abstract Background: Acute vaso-occlusive crisis (...) outcome of decreased pain was graded as a moderate. Other outcomes of length of hospital stay and amount of pain medication used were also graded as moderate, however the outcomes of methemoglobin levels and harm were graded as high quality outcomes. Conclusion: It is difficult to clearly state that inhaled nitric oxide does or does not decrease pain in acute vaso-occlusive crisis in patients with Sickle Cell disease. No adverse side effects have been seen, and some patients have reported decreased

Pacific University EBM Capstone Project2011

160. Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial.

Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial. 21364138 2011 03 02 2011 03 07 2016 12 15 1538-3598 305 9 2011 Mar 02 JAMA JAMA Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial. 893-902 10.1001/jama.2011.235 Inhaled nitric oxide has shown evidence of efficacy in mouse models of sickle cell disease (SCD), case series of patients with acute chest syndrome, and 2 small placebo (...) oxide and placebo groups, with a median time to resolution of crisis of 73.0 hours (95% confidence interval [CI], 46.0-91.0) and 65.5 hours (95% CI, 48.1-84.0), respectively (P = .87). There were no significant differences in secondary outcome measures, including length of hospitalization, visual analog pain scale scores, cumulative opioid usage, and rate of acute chest syndrome. Inhaled nitric oxide was well tolerated, with no increase in serious adverse events. Increases in venous methemoglobin

JAMA2011 Full Text: Link to full Text with Trip Pro